News & Articles
Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
-- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Schizophrenia
This study will evaluate an investigational medication for schizophrenia. Participants must be diagnosed with schizophrenia and be aged 18 to 65.
The research...
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Cattle Vaccines May Reduce E. coli Outbreaks in Humans
Vaccinating cattle against E. coli bacteria could significantly improve the safety of beef...
FRIDAY, Dec. 4 -- Timing of surgical repair or reconstruction of multiple-ligament knee injuries may not affect patient outcome, a new study has found.
Multiple-ligament knee injuries result from traumatic knee dislocations that can occur in...
FRIDAY, Dec. 4 -- Increased exercise, reduced soda consumption and self-weighing are among the most effective weight control strategies for adolescents, a new study shows.
Researchers surveyed 130 adolescents about their weight-control strategies...
FRIDAY, Dec. 4 -- The makers of 24 different prescription painkillers on Friday presented federal regulators with plans to curb the abuse of these opioid drugs.
The pharmaceutical companies have been under pressure from U.S. Food and Drug...
Pharma Industry News
From Associated Press (December 4, 2009)
WASHINGTON--Pharmaceutical executives are laying out plans to
prevent the misuse of prescription painkillers, under pressure from
regulators trying to prevent hundreds of fatal overdoses...
- New report recommends banning gifts and free meals and
mandating disclosure of financial ties between doctors and drug
companies
Trenton, NJ, Dec. 3, 2009 - Attorney General Anne Milgram
today released a report from the Division of Consumer...
From Associated Press (December 4, 2009)
LONDON--Pharmaceutical company AstraZeneca PLC said Friday it
has won U.S. approval for use of its schizophrenia drug Seroquel XR
as an add-on treament for major depressive disorder.
But the London-based...
From Associated Press (December 4, 2009)
LONDON--The European Medicines Agency warns that young children
given GlaxoSmithKline’s swine flu shot may get a fever after
their second dose.
In a statement issued Friday, the European drug regulator...
From Associated Press (December 3, 2009)
WASHINGTON--A consumer advocacy group is petitioning the government
to ban the weight loss pill Meridia because a recent study suggests
it increases risk of heart attack, stroke and death.
A letter...
New Drug Approvals
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 1, 2009 - Dyax Corp. announced today that the U.S. Food and Drug
Administration (FDA) has granted approval for
Kalbitor (ecallantide) for the treatment of
acute attacks of hereditary angioedema (HAE) in...
PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Novo Nordisk
said today that the U.S. Food and Drug Administration (FDA) has
approved a 10 mcg dose formulation of Vagifem (estradiol
vaginal tablets) for the treatment of atrophic vaginitis due...
WHITEHOUSE STATION, N.J.--Merck & Co. and Santarus Inc. said
Tuesday the Food and Drug Administration approved Merck’s
over-the-counter version of the Santarus prescription heartburn
drug Zegerid.
San Diego-based Santarus had partnered with...
BRIDGEWATER, N.J., Nov. 25 /PRNewswire/ -- The FDA granted
traditional approval for Intelence (etravirine) tablets, a
non-nucleoside reverse transcriptase inhibitor (NNRTI). Intelence
is the only NNRTI specifically indicated for use...
INDIANAPOLIS, Nov 30, 2009 /PRNewswire-FirstCall via COMTEX News
Network/ -- The U.S. Food and Drug Administration (FDA) has
approved Cymbalta (duloxetine HCl)
for the maintenance treatment of generalized anxiety disorder (GAD)
in adults, Eli...
New Drug Applications
CHADDS FORD, Pa., Dec. 3 /PRNewswire-FirstCall/ -- Endo
Pharmaceuticals today announced that it received a
complete response letter from the U.S. Food and Drug Administration
(FDA) regarding the New Drug Application (NDA) for...
JERUSALEM--(BUSINESS WIRE)--Dec 1, 2009 - Teva Pharmaceutical
Industries Ltd. (NASDAQ: TEVA), today announced the submission of a
Biologics License Application (BLA) with the U.S. Food and Drug
Administration (FDA) for XM02, a granulocyte...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 2, 2009 - Javelin
Pharmaceuticals, Inc., a leading developer and
marketer of specialty pharmaceutical products for pain management,
today announced that it has submitted a New Drug Application (NDA)
to the...
DARMSTADT, Germany, November 30, 2009 – Merck KGaA
announced today that its US affiliate received a refuse to file
letter from the US Food and Drug Administration (FDA) on the New
Drug Application (NDA) for Cladribine Tablets, Merck...
ROCKVILLE, Md.--(BUSINESS WIRE)--Nov 25, 2009 - Human Genome
Sciences, Inc. (Nasdaq: HGSI) today announced that it has submitted
a Biologics License Application (BLA) to the U.S. Food and Drug
Administration (FDA) for Zalbin (albinterferon...
Clinical Trials
Results Demonstrate Positive Proof of Mechanism
SAN DIEGO, Dec. 3 /PRNewswire/ -- Amira Pharmaceuticals, Inc.
announced today initial positive data from a Phase 1 clinical study
of AM461, the Company's second oral selective antagonist of the...
- SPC3649 Successfully Inhibits miR-122, a microRNA Important
for Hepatitis C Viral Replication, Thereby Significantly Reducing
Hepatitis C Virus in the Bloodstream in Chimpanzees Chronically
Infected With the Hepatitis C Virus
- SPC3649...
Investigators Presented Results at the Society of Urologic
Oncology Annual Meeting
BETHESDA, Md., Dec. 4 /PRNewswire/ -- Drs. Neal Shore and E.
David Crawford presented results for prostate-specific antigen
(PSA) recurrence from the additional...
New Data Shows PharmAthene's Lyophilized rPA Anthrax Vaccine
Could Provide a Stable Cold-Chain-Free Vaccine for Potential
Storage and Distribution at Room Temperature
ANNAPOLIS, Md., Dec. 4 /PRNewswire-FirstCall/ -- PharmAthene,
Inc. (NYSE Amex:...
Review of clinical trials of oral insulin published this month
in Diabetes, Obesity and Metabolism
WORCESTER, MA, December 3, 2009 (GlobeNewswire) –
Published in the journal Diabetes, Obesity and Metabolism, an
independent review of clinical...
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
Monthly Update Archive
